Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/1995
08/23/1995CN1107146A A process for preparing a composition containing benzoheterocycles
08/23/1995CN1107144A Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
08/23/1995CN1107064A Fat reducing pill and producing technology
08/23/1995CN1029541C Nutritional composition and process for its production
08/22/1995US5444090 Applying a synthetase inhibitor
08/22/1995US5444043 Cyclic depsipeptide non-steroidal antiinflammatory agent
08/22/1995US5443848 Administering certain ratios of sodium chloride and sodium acetate; treating hemorrhagic shock
08/22/1995CA2142919A1 Hydroxylamines with hypoglycemic activity
08/22/1995CA2032231C Substituted oxophthalazinyl acetic acids and analogs thereof
08/22/1995CA1336773C Therapeutic dibenzo-piperazino-azepine derivatives
08/20/1995CA2142741A1 Adhesion receptor antagonists
08/19/1995CA2142513A1 Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
08/17/1995WO1995021843A1 Azacyclic derivatives
08/17/1995WO1995021842A1 Heterocyclic compounds and their preparation and use
08/17/1995WO1995021623A1 Peptides and methods against diabetes
08/17/1995WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
08/17/1995WO1995021601A2 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
08/17/1995CA2182978A1 Peptides and methods against diabetes
08/17/1995CA2182957A1 Heterocyclic compounds and their preparation and use
08/17/1995CA2142556A1 Substituted cyclohexanol esters, their use for treating diseases, and pharmaceutical preparations
08/16/1995EP0667344A1 3-acylamino-5-(polysubstituted phenyl)-1,4-benzodiazepin-2-ones useful as CCK-receptor agonists
08/16/1995EP0667152A1 Oral use of calcium formate for the treatment of calcium deficiency in animals
08/16/1995EP0666914A1 Novel p-selectin ligand protein
08/16/1995EP0666858A1 5-arylindole derivatives and their use as serotonin (5-ht 1?) agonists
08/16/1995EP0666850A1 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8a-g(b))-6-ISOQUINOLINEAMINE DERIVATIVES, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF.
08/16/1995EP0666753A1 Method for the treatment of the complications and pathology of diabetes
08/16/1995EP0666747A1 USE OF 17$g(a)-DIHYDROEQUILENIN FOR LOWERING CHOLESTEROL
08/16/1995EP0666746A1 $g(D)5-ANDROSTENES USEFUL FOR PROMOTING WEIGHT MAINTENANCE OR WEIGHT LOSS AND TREATMENT PROCESS
08/16/1995EP0662830A4 -g(p)-bond aromatic vitamin chelates.
08/16/1995CN1106982A Thiazole or imidazole derivatives as maillard reaction inhibitors
08/16/1995CN1106701A Pharmaceutical composition
08/16/1995CN1106698A Prolonged delivery of peptides
08/16/1995CN1106666A Pharmaceutical use of 24-homo-vitamin-D-derivative
08/15/1995US5442101 Methylenebisphosphonic acid derivatives
08/15/1995US5441986 Estrogen agonists as remedies for prostate and cardiovascular diseases
08/15/1995US5441976 Immunostimulants
08/15/1995US5441975 Anticholesterol agent
08/15/1995US5441962 Administering isoquinolinone derivatives
08/15/1995US5441945 Heterocyclic iminobismethylenebisphosphonic acid derivatives
08/15/1995US5441933 Containing diluent, lubricant, disintegrating agent and/or binder
08/15/1995US5441731 Compounds
08/15/1995CA2142411A1 Polysubstituted 3-acylamino-5-phenyl-1,4- benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them
08/10/1995WO1995020979A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
08/10/1995WO1995020964A1 Oral liquid compositions containing paroxetine resinate
08/10/1995WO1995020949A1 Improving glucose tolerance
08/10/1995CA2182731A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
08/10/1995CA2182593A1 Oral liquid compositions containing paroxetine resinate
08/09/1995EP0666250A1 Derivatives of N-(3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphthalene-2-carboxamide having neuroprotective and anti-ischemic properties, their preparation and their use, in therapy
08/09/1995EP0665752A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
08/09/1995EP0665750A1 Benzo-fused lactams promote release of growth hormone
08/09/1995EP0665748A1 Benzo-fused lactams promote release of growth hormone
08/09/1995EP0659179A4 Benzo-fused lactams promote release of growth hormone.
08/09/1995EP0403631B1 Method of making high density solder bumps and a substrate socket for high density solder bumps
08/09/1995CN1106401A Novel macrolides and the use thereof
08/09/1995CN1106397A Condensed cyclic compounds and their use
08/09/1995CN1106396A Intermediates useful in the production of aromatic amino-alcohol derivatives having anti-diabetic an21443/o1besity properties
08/09/1995CN1106286A Fat-reducing granules
08/09/1995CN1106271A Method for prepn. of medicinal introducing bag for treating diabetes mellitus
08/08/1995US5440019 Processes of producing amylase inhibitors
08/08/1995US5439909 2-Substituted with amide or thioamide group; antioxidant for lipoproteins, antilipemic agents, anticholesterol agents
08/08/1995US5439894 Portion of hydroxyl groups of dextrin replaced by amine groups or residues; antacids
08/08/1995CA1336580C Compositions and methods for achieving improved physiological response to exercise
08/04/1995CA2141729A1 N-(3-aminopropyl)-n-phenyl-5,6,7,8-tetrahydro-naphthalene -2-carboxamide derivatives, their preparation and their therapeutic use
08/03/1995WO1995020587A1 Neuroprotective chroman compounds
08/03/1995WO1995020398A1 Human growth hormone
08/03/1995WO1995004720A3 Gastrin and cck receptor ligands
08/03/1995CA2182205A1 Human growth hormone
08/02/1995EP0665245A1 Preparation of crosslinked anion exchange particles
08/02/1995EP0665001A1 Topical slimming composition containing two types of liposomes and its use
08/02/1995EP0664801A1 Amide derivatives
08/02/1995EP0664789A1 Inhibitors of farnesyl protein transferase
08/02/1995EP0664780A1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals
08/02/1995CN1106067A Enzymatic hydroxylation process for the preparation HMG-COA reductase inhibitors and intermediates thereof
08/02/1995CN1106013A Therapeutic or preventive agents for diseases associated with peroxyli peroxylipid
08/02/1995CN1106003A Inhibitors of microsomal triglyceride transfer protein and method
08/02/1995CN1105984A Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
08/02/1995CN1105882A Parathyroid hormone and raloxifene for increasing bone mass
08/02/1995CN1105858A Pyrimidones and imidazolinones for treatment of shock
08/02/1995CN1029403C 2-oxo-1-oxa-8-azaspiro|4,5¨ decane derivatives, pharmaceutical compositions containing them and process for preparing-same
08/01/1995US5438136 Benzo-fused macrocycles promote release of growth hormone
08/01/1995US5438074 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
08/01/1995US5438048 Used for treatment of disorders related to metabolism of calcium and other bivalent metals; treats bone cancer, urolithiasis, rheumatoid arthritis, bone infection and bone degradation
08/01/1995US5438040 Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
08/01/1995CA2018477C Process for preparing 4-amino-1-hydroxybutylidene-1, 1-bisphosphonic, acid monosodium salt trihydrate
08/01/1995CA2000911C Aqueous extract from pittosporaceae effective for diabetes and liver complaints and process for preparing the same
08/01/1995CA1336516C Acyl derivatives of 2-amino-4-substituted-5-hydroxy pyrimidines
08/01/1995CA1336514C Cyclo-octane neuroprotective agents
08/01/1995CA1336505C L-carnitine enriched pet food
07/1995
07/27/1995WO1995019968A1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
07/27/1995WO1995019959A1 Amino acid derivatives and their use as phospholipase a2 inhibitors
07/27/1995WO1995019775A1 A pharmaceutical composition with improved bio-availability of inositol phosphate
07/27/1995WO1995019767A1 Guanylhydrazones for treating inflammatory conditions
07/27/1995WO1995019706A1 Inhibitors of fatty acid synthesis as antimicrobial agents
07/27/1995CA2181031A1 Inhibitors of fatty acid synthesis as antimicrobial agents
07/26/1995EP0664290A1 Mono- and di-esters of cinnamic acid or of one of his derivatives and of vitamine C, their process of preparation and their use as antioxydants in cosmetic, pharmaceutical or alimentary compositions
07/26/1995EP0664287A1 Vitamin D Compounds and method of preparing these compounds
07/26/1995EP0664129A2 Epicholesterol for treating dyslipidemia
07/26/1995EP0664122A1 Inhibition of imperfect tissue repair
07/26/1995EP0664121A1 Inhibition of ldl oxidation and atherosclerosis
07/26/1995EP0663902A1 25-carboxylic acid derivatives in the vitamin d series, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines
1 ... 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 ... 1298